Health Trials

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section

ConditionsOndansetronLozengeIntravenousPreventionShiveringCesarean Section
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorTanta University

About this trial

This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).

Eligibility criteria

Qualifiers

Age from 18 to 40 years.

American Society of Anesthesiology (ASA) physical status II.

Parturient women undergoing cesarean section under spinal anesthesia.

Disqualifiers

Parturient women with any contraindication or hypersensitivity to the study drugs.

Any history of cardiovascular diseases, psychosis, hypertension, fetal distress, cord prolapse initial.

Preoperative shivering.

Preoperative fever (>38°C).

Trial design

Treatments tested in this trial

  • Ondansetron lozenge
  • Ondansetron intravenous

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Tanta University

Lead sponsor

Source ClinicalTrials.gov